[1]Philley JV, Griffith DE. Management of nontuberculous mycobacterial (NTM) lung disease. Semin Respir Crit Care Med,2013,34(1):135-142. [2]陈品儒,蔡杏珊,肖芃,等. 致病性速生型非结核分枝杆菌MIC法检测及药敏结果分析.广东医学,2012,33(23):3620-3623. [3]潘玲玲,许宏,林德智. 医院龟分枝杆菌感染流行病学调查. 中国消毒学杂志, 2009,26(6):695. [4]Wang X, Barnes PF, Huang F,et al. Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses. J Immunol, 2012,189(6):3092-3103. [5]Hunt DM, Sweeney NP, Mori L, et al. Long-range transcriptional control of an operon necessary for virulence-critical ESX-1 secretion in Mycobacterium tuberculosis. J Bacteriol, 2012,194(9):2307-2320. [6]Scott-Lang VE, Sergeant A, Sinclair CG, et al. Cutaneous Mycobacterium chelonae infection in Edinburgh and the Lo-thians, South-East Scotland, U.K. Br J Dermatol,2014,171(1):79-89. [7]Abdallah AM, Gey van Pittius NC, Champion PA, et al. Type VII secretion-mycobacteria show the way. Nat Rev Microbiol, 2007,5(11):883-891. [8]熊礼宽.结核病实验诊断学.北京:人民卫生出版社,2003:100-116. |